1. A retrospective review of transcutaneous and transconjunctival dual approach—A technique for mini-invasive double eyelid blepharoplasty with blepharoptosis correction
- Author
-
Yu-Hsin Wang, Sindy Hu, Shyue-Luen Chang, Mei-Ching Lee, and Yau-Li Huang
- Subjects
Blepharoplasty ,Retrospective review ,medicine.medical_specialty ,business.industry ,medicine.medical_treatment ,Levator function ,Eyelids ,Retrospective cohort study ,Double eyelid ,eye diseases ,Surgery ,Mini invasive surgery ,Treatment Outcome ,medicine.anatomical_structure ,Oculomotor Muscles ,medicine ,Blepharoptosis ,Humans ,Revision rate ,Eyelid ,business ,Retrospective Studies - Abstract
Many Oriental eyes feature single eyelid fold and ptotic eyelid. Performing the double eyelid blepharoplasty (DEB) in a minimally invasive manner with simultaneous blepharoptosis correction (BPC) is important to achieve an aesthetic pleasing outcome.To demonstrate an effective mini-invasive transcutaneous and transconjunctival dual approach technique for simultaneous DEB and BPC. Furthermore, to compare the outcome of BPC in dual approach, transcutaneous procedure and transconjunctival procedure.This is a retrospective study reviewing 159 eyelids that underwent mini-invasive DEB with BPC from November 2018 to May 2019, including the technical description and the surgical outcomes. To investigate the efficacy, the pre- and postoperative margin reflex distance 1 (MRD1) and levator function (LF) corresponding to the different surgical procedures and preoperative severity was analyzed.Statistically, the dual approach group has significant improvement in MRD1 and LF (47 eyelids, p0.05) corresponding to patients with ptosis of any severity. Under the same tucking amount, dual approach can achieve 1.6±0.7 mm of MRD1 improvement, which is nearly twice the amount compare with transconjunctival approach alone. No revision nor complication noted in the dual approach group by 6-month follow-up.The dual approach technique is a method with a wide range of applications, effective, and low revision rate that simultaneously correct blepharoptosis and create a double eyelid.
- Published
- 2022
- Full Text
- View/download PDF